An interventional study of Persona Partial Knee (PPK) and Triathlon cruciate-retaining total knee system. in Osteoarthritis, Knee and Arthroplasty, sponsored by Golden Jubilee National Hospital. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-24.
Sponsored by Golden Jubilee National Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 167 studies in Osteoarthritis with a site in United Kingdom — 14 open to participants now, 38 under way, 1 of them phase 3. Osteoarthritis · United Kingdom.
Among the 167 studies in Osteoarthritis with a site in United Kingdom, this one is the 89th largest by planned enrollment of the 114 interventional ones that give a count, is one of 5 that started in 2021, is one of 59 with no phase, reaches primary completion later than 18 of the 37 other live ones, and was the 134th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →14 of the 167 studies in Osteoarthritis with a site in United Kingdom are open now. Recruiting first, the newest first:
Golden Jubilee National Hospital · Sites in United Kingdom
Ages 18+
Eli Lilly and Company · Sites in United Kingdom, United States, Argentina and 10 more countries
Ages 18+
Middlesex University · Sites in United Kingdom
Ages 18+
University College, London · Sites in United Kingdom
Ages 18+
Scarcell Therapeutics S.A.S. · Sites in United Kingdom
Ages 40+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
167 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 13 · Phase 3 19 · Phase 4 16
First in 1997; this study’s year is marked. 5 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 108 across the 114 interventional studies, 150 across the 53 observational. Of the 110 that completed or were terminated, 28 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
105 of 167 have an industry lead sponsor. The 10 most frequent:
Golden Jubilee National Hospital is the lead sponsor of 30 studies on the registry; 4 are open to participants now.
Golden Jubilee National Hospital has 5 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
10 of the studies in Osteoarthritis with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06550024CrannMedSakuraBead Used as Resorbable Embolic for Genicular Artery Embolization | 2026-12 |
| NCT01480440Zimmer BiometOutcomes Study of the Trabecular Metal (TM) Reverse Shoulder System | 2026-12 |
| NCT02337244Zimmer, GmbHZimmer POLAR Persona - TKA (EMEA Study) | 2026-12 |
| NCT05889598Loughborough UniversityResistance Exercise Training to Improve Bone and Articular Cartilage Health in Women | 2026-12-31 |
| NCT03372278Zimmer BiometPMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty | 2027-01 |
Add all 10 to your calendar (.ics) → With an account.
Among the 167 studies in Osteoarthritis with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
For patients with osteoarthritis affecting only the inner part of the knee, surgeons can offer either a partial knee replacement, which resurfaces the worn compartment alone, or a total knee replacement. Both are recommended treatments, but there is no agreement on when to choose one over the other. Partial knee replacement preserves the anterior cruciate ligament and more of the natural knee, and recovery is usually quicker, but it is used in only about one in ten knee replacements in the United Kingdom.
Studies comparing the two have mostly relied on patient questionnaires, which may not be sensitive enough to detect differences in how the knee actually functions. Studies that have measured movement directly have concentrated on level walking, which is not demanding enough to separate the two operations. Difficulty with stairs is one of the longest lasting problems patients report after knee replacement.
The FLEX-UNI trial will compare the two operations using three-dimensional motion analysis during more demanding everyday activities. Forty patients who are suitable for a partial knee replacement will be randomly allocated to receive either a partial or a total knee replacement. Patients and the researchers measuring their movement will not know which operation was performed. The main measurement is how far the operated knee bends while stepping down from a 20 cm step, measured one year after surgery. Movement during walking, stair climbing, slopes, sitting and standing, and balance will also be measured, along with questionnaires, x-rays, and complications. Results will be compared against measurements from people with healthy knees.
FLEX-UNI is a single-centre, prospective, randomized, double-blinded, controlled superiority trial comparing medial unicompartmental knee arthroplasty (UKA) with total knee arthroplasty (TKA) in patients with anteromedial knee osteoarthritis. Forty participants will be randomized 1:1. The trial is conducted at a high-volume elective arthroplasty centre and participants are followed for 12 months.
Participants are identified from the clinic lists of participating consultant orthopaedic surgeons and screened against the eligibility criteria by a member of the research team and by the treating consultant. Following written consent and baseline assessment, participants are randomized using sequentially numbered, opaque, sealed envelopes prepared and opened by a member of the research team not involved in screening, recruitment, or outcome assessment.
Participants allocated to UKA receive a cemented medial fixed-bearing Persona Partial Knee (Zimmer Biomet, Warsaw, Indiana, USA), implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment. Participants allocated to TKA receive a cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA), implanted using a measured resection technique with a mechanical alignment target. Both procedures use conventional manual instrumentation, without robotic assistance or computer navigation, and are performed by the same group of consultant surgeons, each of whom performs both operations.
Suitability for medial UKA is confirmed intraoperatively at arthrotomy in all participants, including those allocated to TKA. Participants allocated to UKA who are found at arthrotomy to be unsuitable, principally because of disease progression beyond anteromedial osteoarthritis or a deficient anterior cruciate ligament, undergo TKA.
Participants are blinded to allocation. A standard-size sterile dressing is applied to the surgical wound by an independent healthcare support worker before biomechanical testing to conceal scar length, and participants are not shown their postoperative radiographs unless there is a clinical need. Research staff performing biomechanical assessment, outcome scoring, and statistical analysis are blinded to allocation, with unblinding only after analysis is complete. The treating surgeon cannot be blinded.
Assessments take place preoperatively, immediately postoperatively, and at six weeks, six months, and 12 months. Biomechanical assessment is performed in the centre's Motion Analysis Laboratory using a Vicon motion capture system (Vicon Motion Systems Ltd, Yarnton, UK) and two AMTI force plates (Advanced Mechanical Technology Inc., Watertown, Massachusetts, USA). Tasks are level walking, incline walking, decline walking, step ascent, step descent, sit-to-stand-to-sit, and single-leg balance.
A matched healthy control group is drawn from an existing motion analysis database held at the study centre, comprising individuals without known knee pathology previously assessed using an identical protocol under separate ethical approval. Control data do not contribute to the primary comparison between arms and are used only to contextualize findings against values expected in a healthy population. Healthy controls are not prospectively enrolled in this trial.
The sample size was calculated for the primary outcome, assuming 95 degrees for the UKA group and 89 degrees for the TKA group with a pooled standard deviation of 5.5 degrees, two-sided alpha of 0.05, and 80% power, giving 15 participants per group for an analysis of covariance with baseline as a covariate. Allowing for an estimated 10% intraoperative conversion from UKA to TKA and 15% loss to follow-up, the recruitment target is 20 per group. The trial is powered for the primary outcome alone, and all secondary outcomes are exploratory.
The primary analysis is performed on the per-protocol population, defined as participants who received their randomized implant and completed the 12-month biomechanical assessment. Participants found intraoperatively unsuitable for UKA at arthrotomy are excluded from the primary analysis regardless of allocation.
The trial is funded by Zimmer GmbH (Winterthur, Switzerland).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Description: Cemented medial fixed-bearing unicompartmental knee arthroplasty, implanted using a spacer block technique that resurfaces the medial compartment without deliberate correction of limb alignment, using conventional manual instrumentation
Device: Persona Partial Knee (PPK)
Cemented cruciate-retaining total knee arthroplasty without patellar resurfacing, implanted using a measured resection technique with a mechanical alignment target, using conventional manual instrumentation. This is the standard total knee implant used at the study centre.
Device: Triathlon cruciate-retaining total knee system.
Cemented medial fixed-bearing unicompartmental knee arthroplasty using the Persona Partial Knee (PPK; Zimmer Biomet, Warsaw, Indiana, USA).
Cemented Triathlon cruciate-retaining total knee system without patellar resurfacing (Stryker, Mahwah, New Jersey, USA).
Maximum knee flexion of the operated knee during step descent
Peak flexion angle of the operated knee in the sagittal plane, in degrees, during descent from a 20 cm step with the operated limb acting as the trailing limb, measured using three-dimensional motion analysis.
Time frame: 12 months post-operatively
Maximum knee flexion during step descent, operated limb as trailing limb
Time frame: 6 months post-operatively
Knee kinematics and kinetics
Knee kinematics: sagittal, coronal, and transverse plane joint angles during level walking, incline walking, decline walking, step ascent, step descent, and sit-to-stand-to-sit. Knee kinetics: knee joint moments and ground reaction forces during tasks performed on force plates.
Time frame: baseline, 6 months, 12 months
Spatiotemporal and balance
Spatiotemporal gait parameters: walking speed and step length. Single-leg balance: time to failure, in seconds.
Time frame: baseline, 6 months, 12 months.
Patient satisfaction
Patient satisfaction on a Fpur-point Likert scale.
Time frame: 6 weeks, 6 months, 12 months
Radiographic assessment
11\. Radiographic assessment of implant position, alignment, and signs of loosening or migration, using a modified Knee Society Roentgenographic Evaluation and Scoring System. No summary score is produced.
Time frame: to 12 months postoperatively
Complications and adverse events
12\. Complications and adverse events, including deep and superficial infection, thromboembolic events, intraoperative fracture, neurovascular injury, wound complications, and any reoperation or revision.
Time frame: to 12 months postoperatively
Implant survivorship
Implant survivorship, reported as the number of implants in situ.
Time frame: 12 months
Intraoperative conversion from unicompartmental to total knee arthroplasty, reported as the number of participants.
Time frame: day of surgery
Patient reported outcome (Oxford Knee Score)
Oxford Knee Score, 12 items, total score 0 to 48, higher scores indicate better outcome.
Time frame: baseline, 6 weeks, 6 months, 12 months.
Patient reported outcome (EuroQual 5D-5L questionnaire)
9\. EQ-5D-5L index value and visual analogue scale.
Time frame: baseline, 6 weeks, 6 months, 12 months.
Patient reported outcome (Forgotten Joint Score)
Forgotten Joint Score-12, score 0 to 100, higher scores indicate greater ability to forget the operated joint.
Time frame: 6 weeks, 6 months, 12 months.
Patient reported outcome (University of California Los Angelees Activity Score)
8\. UCLA Activity Score, single item, 1 to 10, higher scores indicate greater activity.
Time frame: baseline, 6 weeks, 6 months, 12 months.
Plan to share: No
Started Apr 2021 (actual). Primary completion is estimated for Oct 2027, 77 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 77 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Golden Jubilee National Hospital